It was barely two hours after a panel recommended to the Food and Drug Administration that it allow the drug Tysabri back on the market when Dr. Joseph Berger got an e-mail inviting him to a special class.
The
Star-Telegram
Simplifying Global Compliance
Recommended Products
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
This management report includes more than 650 items organized in three sections covering all aspects of quality manufacturing.
Biological Risk Evaluation and Management for Medical Devices
Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
Editor's Picks
OssDsign’s Regenerative Cranial Implant Cleared by FDA
The implant’s ceramic component resorbs and is eventually replaced by bone through the healing process.
EMA Blocks Aurobindo Pharma From Supplying Irbesartan
EU authorities have increased scrutiny of Chinese API maker Zhejiang Huahai, the valsartan manufacturer linked to the original contamination of APIs used in blood pressure drugs.
FDAnews Drug Daily Bulletin
WITH MS DRUG STATUS IN LIMBO, FIRMS WORK ON PATIENT CONFIDENCE
May 12, 2006